Works matching IS 14783223 AND DT 2022 AND VI 42 AND IP 1
Results: 33
Binge drinking and fibrogenesis: More than just a hangover.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 6, doi. 10.1111/liv.15119
- By:
- Publication type:
- Article
Inside Front Cover.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. ii, doi. 10.1111/liv.15146
- By:
- Publication type:
- Article
Issue Cover.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. i, doi. 10.1111/liv.15145
- By:
- Publication type:
- Article
NAFLD vs ALD: The unresolved duel between the bad and the worst.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 260, doi. 10.1111/liv.15125
- Publication type:
- Article
Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO‐C3).
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 92, doi. 10.1111/liv.15120
- By:
- Publication type:
- Article
Back Cover.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. iii, doi. 10.1111/liv.15147
- By:
- Publication type:
- Article
Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two‐dimensional shear wave elastography in non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 102, doi. 10.1111/liv.15116
- By:
- Publication type:
- Article
Albumin for AKI in cirrhosis – Sham therapy or effective?
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 258, doi. 10.1111/liv.15114
- By:
- Publication type:
- Article
Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 161, doi. 10.1111/liv.15090
- By:
- Publication type:
- Article
Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 180, doi. 10.1111/liv.15089
- By:
- Publication type:
- Article
Risk factors for bleeding hepatocellular adenoma in a United States cohort.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 224, doi. 10.1111/liv.15087
- By:
- Publication type:
- Article
On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 59, doi. 10.1111/liv.15085
- By:
- Publication type:
- Article
Hepatitis Delta virus in migrants: The challenge of elimination (ANRS CO22 HEPATHER cohort).
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 249, doi. 10.1111/liv.15106
- By:
- Publication type:
- Article
Improvement in adipocytic indices as a predictor of improved outcomes after TIPS: Right conclusion?
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 253, doi. 10.1111/liv.15091
- By:
- Publication type:
- Article
Impact of COVID – 19 in patients awaiting liver transplantation.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 256, doi. 10.1111/liv.15105
- By:
- Publication type:
- Article
Gamma‐Glutamyl Transferase (γ‐GT) – an old dog with new tricks?
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 9, doi. 10.1111/liv.15099
- By:
- Publication type:
- Article
Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 187, doi. 10.1111/liv.15096
- By:
- Publication type:
- Article
A typical autoimmune hepatitis (AIH) case following Covid‐19 mRNA vaccination. More than a coincidence?
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Rapid detection for infected ascites in cirrhosis using metagenome next‐generation sequencing: A case series.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 173, doi. 10.1111/liv.15083
- By:
- Publication type:
- Article
Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 210, doi. 10.1111/liv.15082
- By:
- Publication type:
- Article
Association of genetic variations with NAFLD in lean individuals.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 149, doi. 10.1111/liv.15078
- By:
- Publication type:
- Article
Maternal and fetal outcomes of pregnancies complicated by acute hepatitis E and the impact of HIV status: A cross‐sectional study in Namibia.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 50, doi. 10.1111/liv.15076
- By:
- Publication type:
- Article
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 26, doi. 10.1111/liv.15070
- By:
- Publication type:
- Article
A novel quantitative ultrasound technique for identifying non‐alcoholic steatohepatitis.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 80, doi. 10.1111/liv.15064
- By:
- Publication type:
- Article
Higher dietary insulinaemic potential is associated with increased risk of liver steatosis and fibrosis.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 69, doi. 10.1111/liv.15057
- By:
- Publication type:
- Article
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 38, doi. 10.1111/liv.15056
- By:
- Publication type:
- Article
Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 199, doi. 10.1111/liv.15051
- By:
- Publication type:
- Article
The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 233, doi. 10.1111/liv.15049
- By:
- Publication type:
- Article
The effect of biliary obstruction, biliary drainage and bile reinfusion on bile acid metabolism and gut microbiota in mice.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 135, doi. 10.1111/liv.15047
- By:
- Publication type:
- Article
Bile acid dysmetabolism in the gut‐microbiota‐liver axis under hepatitis C virus infection.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 124, doi. 10.1111/liv.15041
- By:
- Publication type:
- Article
The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 16, doi. 10.1111/liv.15027
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 1, doi. 10.1111/liv.14951
- Publication type:
- Article
Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 112, doi. 10.1111/liv.15039
- By:
- Publication type:
- Article